$1.22
-0.05-3.94%
At close: -
$1.20
-0.02-1.64%
After Hours: Nov 20, 4:40 PM EDT
Comments
Loading...
XORTX Therapeutics (NASDAQ:XRTX) Stock, Earnings Estimates, EPS, And Revenue
XORTX Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 15
EPS
$-0.200
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of XORTX Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
XORTX Therapeutics (XRTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-10 | $1.36 | $-0.44 | 409.1 % |
| Sep 2023 | 2023-11-16 | $-0.67 | $-0.19 | -252.6 % |
| Mar 2023 | 2023-04-03 | $-1.35 | $-1.44 | 6.25 % |
XORTX Therapeutics (XRTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?
XORTX Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 15, 2024 for Q3.
What were the latest earnings per share (EPS) for XORTX Therapeutics (NASDAQ:XRTX)?
XORTX Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 15, 2024 for Q3 and the Actual EPS was $-0.20, which missed the estimate of $0.00.
What were XORTX Therapeutics’s (NASDAQ:XRTX) revenues?
XORTX Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 15, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.